Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Koza

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Leukemia|August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registryM Michallet, M Sobh, D Milligan, et al.
Vnitrni Lekarstvi|September 28, 1998
[Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group]Z Adam, M Krejcí, J Bacovský, et al.
Blood|November 10, 1998
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working PartyE Carreras, H Bertz, W Arcese, et al.
Bone Marrow Transplantation|January 31, 1998
Donor work-up and transport of bone marrow--recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA)S A Cleaver, P Warren, M Kern, et al.
British Journal of Haematology|June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopeniaJ R Passweg, M Rabusin, M Musso, et al.
Vnitrni Lekarstvi|April 24, 2002
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma]Z Adam, L Pour, A Svobodník, et al.
Vnitrni Lekarstvi|November 6, 2001
[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group]M Krejcí, R Hájek, V Scudla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseR Saccardi, T Kozak, C Bocelli-Tyndall, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Leukemia|August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registryM Michallet, M Sobh, D Milligan, et al.
Vnitrni Lekarstvi|September 28, 1998
[Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group]Z Adam, M Krejcí, J Bacovský, et al.
Blood|November 10, 1998
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working PartyE Carreras, H Bertz, W Arcese, et al.
Bone Marrow Transplantation|January 31, 1998
Donor work-up and transport of bone marrow--recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA)S A Cleaver, P Warren, M Kern, et al.
British Journal of Haematology|June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopeniaJ R Passweg, M Rabusin, M Musso, et al.
Vnitrni Lekarstvi|April 24, 2002
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma]Z Adam, L Pour, A Svobodník, et al.
Vnitrni Lekarstvi|November 6, 2001
[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group]M Krejcí, R Hájek, V Scudla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseR Saccardi, T Kozak, C Bocelli-Tyndall, et al.
Pageof 6